Recent Updates
Recently added Catalysts
ENOV Positive Sentiment Score: 70/100

Enovis announces webcast and conference call for Third Quarter 2025 Results and participation in upcoming investor conferences

Key Takeaway: Enovis Corporation announced it will host a conference call and live webcast on November 6, 2025, to discuss its third quarter financial results. The company will also participate in various investor conferences. Investors can access the webcast and a replay on Enovis' website, enhancing transparency and communication.

Market Sentiment Analysis

POSITIVE FACTORS

  • Enovis is hosting a conference call to discuss strong financial results.
  • The company is actively engaging with investors through multiple conferences.
  • A live webcast will provide accessibility to financial updates.

Full Press Release Details

Dallas, TX, Oct. 24, 2025 (GLOBE NEWSWIRE) -- Enovis™ Corporation (“Enovis” or “the Company”) (NYSE: ENOV), an innovation-driven medical technology growth company, announced today it will host an investor conference call and live webcast to discuss its third quarter 2025 financial results on Thursday, November 6th, 2025, at 8:30 a.m. Eastern Time and issue an earnings press release earlier that morning. A presentation related to the call, as well as a webcast, will be made available on the "Investors" section of Enovis' website atwww.enovis.com. Additionally, the company also announced it will participate in the following investor conferences:
A link to the live audio webcasts, as well as a replay of these events, will be available on the Company’s website under the Investors tab at Events and Presentations.

Third Quarter 2025 Conference Call/Webcast Information

Investors can access the live webcast via a link on the Enovis website. For those planning to participate on the call, please dial (800) 715-9871 (U.S. callers) and (646) 307-1963 (International callers) and use conference ID 1691901. A link to a replay of the call will also be available on the Enovis website later that day.

About Enovis

Enovis Corporation (NYSE: ENOV) is an innovation-driven medical technology growth company dedicated to developing clinically differentiated solutions that generate measurably better patient outcomes and transform workflows. Powered by a culture of continuous improvement, global talent and innovation, the Company’s extensive range of products, services and integrated technologies fuels active lifestyles in orthopedics and beyond. The Company’s shares of common stock are listed in the United States on the New York Stock Exchange under the symbol ENOV. For more information about Enovis, please visitwww.enovis.com.

Availability of Information on the Enovis Website

Investors and others should note that Enovis routinely announces material information to investors and the marketplace using SEC filings, press releases, public conference calls, webcasts and the Enovis Investor Relations website. While not all of the information that the Company posts to the Enovis Investor Relations website is of a material nature, some information could be deemed to be material. Accordingly, the Company encourages investors, the media and others interested in Enovis to review the information that it shares on ir.enovis.com.
Kyle RoseVice President, Investor RelationsEnovis Corporationinvestorrelations@enovis.com

Frequently Asked Questions

When will Enovis announce its Q3 2025 results?

Enovis will announce its Q3 2025 results on November 6, 2025.

How can I access the Enovis conference call?

Investors can access the conference call by dialing (800) 715-9871 for U.S. callers.

Where can I find the webcast link for the call?

The webcast link will be available on the Enovis website under the Investors section.

Will there be a replay of the conference call?

Yes, a replay of the conference call will be available on the Enovis website later that day.

Last updated: Oct 24, 2025